Biomarker associated with poor outcome in aggressive childhood cancer

Results from a new study identify a biomarker that may be useful for predicting the outcome of treatment for neuroblastoma, the most common cancer in young children. The research, published by Cell Press in the 7th April issue of the journal Cancer Cell, also provides new information about the molecular signals that are involved in the progression of this often devastating paediatric cancer...

Read the whole article on

More from